公司资料
Verastem, Inc. 股价、新闻与催化剂
- 股票代码:
- VSTM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.86 USD (-0.44%)
收盘价
最后更新: 2026年8月24日
335M USD
市值
股价为何变动
As of Aug 24, 2026, VSTM closed down 0.44% at $6.86. No new same-company headline was identified in the current news window.
公司概览
业务概览
Verastem is a biotechnology company focused on oncology and rare-disease pathways, including targeted cancer programs. Its story has centered on developing therapies for difficult-to-treat tumors.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Verastem sits in specialty oncology biotechnology.
商业模式特征
The business depends on clinical validation, product development, and the ability to create a focused cancer franchise.
生物医药行业定位
Verastem is a catalyst-driven oncology name whose stock reacts to development and strategic milestones.
未来催化剂
- Verastem’s catalysts are avutometinib / defactinib and the ovarian-cancer / RAF-pathway development path. Investors will watch whether the combination story can keep building a credible oncology franchise.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。